SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001548233-13-000008
Filing Date
2013-05-20
Accepted
2013-05-20 14:15:31
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q QUARTERLY REPORT cellceutix10q1q13.htm 10-Q 496659
2 EXHIBIT 31-1 ex31-1.htm EX-31 9540
3 EXHIBIT 32-1 ex32-1.htm EX-32 5878
  Complete submission text file 0001548233-13-000008.txt   4357325

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctix-20130331.xml EX-101.INS 509388
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctix-20130331.xsd EX-101.SCH 59902
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctix-20130331_cal.xml EX-101.CAL 29464
7 XBRL TAXONOMY DEFINITION LINKBASE DOCUMENT ctix-20130331_def.xml EX-101.DEF 228492
8 XBRL TAXONOMY LABEL LINKBASE DOCUMENT ctix-20130331_lab.xml EX-101.LAB 416156
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctix-20130331_pre.xml EX-101.PRE 318869
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-52321 | Film No.: 13857761
SIC: 2834 Pharmaceutical Preparations